A Clinical Trial Evaluating the Efficacy and Safety of Dasatinib in Refractory Metastatic GIST

NCT02776878 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

57

Enrollment

OTHER

Sponsor class

Conditions

Gastrointestinal Stromal Tumor

Interventions

DRUG: dasatinib

Sponsor

Peking University Cancer Hospital & Institute